New York, NY, United States of America

Tiang-Chao Chou

This inventor holds 1 USPTO granted patent. Top assignee: Sloan-Kettering Institute for Cancer Research. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tiang-Chao Chou. Retrieved from https://idiyas.com/inventor/tiang-chao-chou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tiang-Chao Chou

Introduction

Tiang-Chao Chou is a notable inventor based in New York, NY (US). He has made significant contributions to the field of cancer research through his innovative work. His research focuses on developing compounds that can inhibit the growth of tumor cells.

Latest Patents

Tiang-Chao Chou holds a patent for "Antitumor cyclopentnaphthoquinone and cyclopentanthraquinone derivatives." This invention provides compounds with specific structures that have potential applications in treating diseases characterized by the proliferation of tumor cells. The patent also includes pharmaceutical compositions containing these compounds and methods for synthesizing them.

Career Highlights

Chou is affiliated with the Sloan-Kettering Institute for Cancer Research, where he conducts his research. His work is pivotal in the ongoing fight against cancer, contributing to the development of new therapeutic strategies.

Collaborations

Some of his notable coworkers include Tsann-Long Su and Kyoichi A Watanabe. Their collaborative efforts enhance the research output and innovation in cancer treatment.

Conclusion

Tiang-Chao Chou's contributions to cancer research through his patented inventions highlight the importance of innovation in medical science. His work continues to inspire advancements in the treatment of tumor-related diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…